A Phase 1 Dose-Escalation Trial of BN-CV301, a Recombinant Poxviral Vaccine Targeting MUC-1 and CEA with Costimulatory Molecules

Por Gatti-Mays, Margaret E., Strauss, Julius, Donahue, Renee N., Palena, Claudia, Rivero, Jaydira Del, Redman, Jason, Madan, Ravi A., Marté, Jennifer N., Cordes, Lisa, Lamping, Elizabeth, Orpia, Alanvin, Burmeister, Andrea, Wagner, Eva, Navarro, Cesar Pico, Heery, Christopher R., Schlom, Jeffrey, Gulley, James L.
Publicado no Clin Cancer Res (2019)